share_log

Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Floyd Eric

SEC announcement ·  Feb 1 05:30
Summary by Futu AI
In a recent transaction, Eric Floyd, associated with Virpax Pharmaceuticals Inc. [VRPX], executed a stock transaction on January 29, 2024. The specific details regarding the nature of the transaction, such as the action type, number of shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Eric Floyd to the issuer was also not specified. Investors are advised to seek additional information to fully understand the implications of this transaction on their investment decisions.
In a recent transaction, Eric Floyd, associated with Virpax Pharmaceuticals Inc. [VRPX], executed a stock transaction on January 29, 2024. The specific details regarding the nature of the transaction, such as the action type, number of shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Eric Floyd to the issuer was also not specified. Investors are advised to seek additional information to fully understand the implications of this transaction on their investment decisions.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.